Clinical trial
Is Insulin Resistance and/or Glucose Intolerance Pathogenetic in the Development of a Reduced Incretin Effect
NCT00784745 is registered in ClinicalTrials.gov with University Hospital, Gentofte, Copenhagen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Is Insulin Resistance and/or Glucose Intolerance Pathogenetic in the Development of a Reduced Incretin Effect
- Lead sponsor
- University Hospital, Gentofte, Copenhagen
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 30, 2008
- Completion date
- September 30, 2009
- Enrollment
- 21 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.